Corrigendum to: Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease

Lignende værker

• Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
  af: Reinisch, Walter, et al.
  Udgivet: (2020)
• Comparative Effectiveness of Infliximab and Adalimumab for Crohn’s Disease
  af: Osterman, Mark T, et al.
  Udgivet: (2013)
• Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis
  af: Keil, Radan, et al.
  Udgivet: (2016)
• Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
  af: Song, Christine H, et al.
  Udgivet: (2012)
• Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
  af: Barberio, Brigida, et al.
  Udgivet: (2020)